Loading...

Shinya Yamanaka, MD, PhD

Title(s)Professor, Anatomy
SchoolSchool of Medicine
Address1650 Owens St
San Francisco CA 94107
Phone415-355-0960
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoPostdoctoral StudiesGraduate Division
    Collapse Awards and Honors
    2013Breakthrough Prize in Life Sciences
    2012Nobel Prize in Physiology or Medicine
    2012Millennium Technology Award
    2011Wolf Prize in Medicine
    2010March of Dimes Prize in Developmental Biology
    2010Kyoto Prize for Advanced Technology
    2009Lasker Basic Medical Research Award
    2008Shaw Prize in Life Science and Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Shinya Yamanaka is a Senior Investigator and the L.K. Whittier Foundation Investigator in Stem Cell Biology at the Gladstone Institute for Cardiovascular Disease (GICD). Dr. Yamanaka is also a Professor of Anatomy at the University of California, San Francisco, as well as the Director of the Center for iPS Cell Research and Application (CiRA) and a Principal Investigator at the Institute for Integrated Cell-Material Sciences, both at Kyoto University.

    Dr. Yamanaka’s research focuses on ways to generate cells resembling embryonic stem cells by reprogramming somatic, or skin, cells. He seeks to understand the molecular mechanisms that underlie pluripotency and the rapid proliferation of embryonic stem cells—they can become any type of cell in the body—and to identify the factors that induce reprogramming.

    Dr. Yamanaka’s discovery that adult somatic cells can be reprogrammed into pluripotent cells has had a profound effect on developmental and stem cell biology. By introducing the genes for four factors that turn genes on and off, he induced the skin cells of adult mice to become like embryonic stem cells, which he called induced pluripotent stem (iPS) cells. This iPS cell technology represents an entirely new platform for fundamental studies of developmental biology. Rather than using disease models made in yeast, flies, mice or other animals, iPS cells can be taken from patients with a specific disease. As a result, they contain a complete set of the genes that resulted in that disease—representing the potential of an almost perfect disease model for studying disease development, new drugs and treatments.

    In 1996, Dr. Yamanaka became an Assistant Professor at Osaka City University Medical School. In 1999, he was appointed Associate Professor at Nara Institute of Science and Technology, where he became a full professor in 2003. He took his current position as a professor at Kyoto University in 2004 and was appointed as a Senior Investigator at the Gladstone Institutes in 2007. Since 2008, he has directed CiRA.

    Dr. Yamanaka has received many awards and honors, including the Albert Lasker Basic Medical Research Award, the Wolf Prize in Medicine, the Millennium Technology Award, the Shaw Prize, the Kyoto Prize for Advanced Technology, the Gairdner International Award, the Robert Koch Award and the March of Dimes Prize.

    Dr. Yamanaka earned an MD from Kobe University in 1987 and a PhD from Osaka City University in 1993. From 1987 to 1989, he was a resident at the National Osaka Hospital. From 1993 to 1996, he was a postdoctoral fellow at GICD.

    Collapse Research 
    Collapse Research Activities and Funding
    Induced Pluripotent Stem Cells in the Understanding and Treatment of Heart Diseas
    NIH/NHLBI U01HL100406Sep 30, 2009 - Jun 30, 2016
    Role: Co-Principal Investigator
    The Epigenetic Landscape of Heart Development
    NIH/NHLBI U01HL098179Sep 30, 2009 - Jul 31, 2015
    Role: Co-Principal Investigator
    Induced pluripotent stem cells in the understanding and treatment of heart diseas
    NIH/NHLBI R03HL096254Dec 1, 2008 - May 31, 2009
    Role: Co-Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges. Cell Stem Cell. 2020 Oct 01; 27(4):523-531. Yamanaka S. PMID: 33007237.
      View in: PubMed   Mentions:    Fields:    
    2. Critical Roles of Translation Initiation and RNA Uridylation in Endogenous Retroviral Expression and Neural Differentiation in Pluripotent Stem Cells. Cell Rep. 2020 Jun 02; 31(9):107715. Takahashi K, Jeong D, Wang S, Narita M, Jin X, Iwasaki M, Perli SD, Conklin BR, Yamanaka S. PMID: 32492424.
      View in: PubMed   Mentions: 1     Fields:    
    3. Base-Resolution Methylome of Retinal Pigment Epithelial Cells Used in the First Trial of Human Induced Pluripotent Stem Cell-Based Autologous Transplantation. Stem Cell Reports. 2019 10 08; 13(4):761-774. Araki H, Miura F, Watanabe A, Morinaga C, Kitaoka F, Kitano Y, Sakai N, Shibata Y, Terada M, Goto S, Yamanaka S, Takahashi M, Ito T. PMID: 31564644.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    4. Induced 2C Expression and Implantation-Competent Blastocyst-like Cysts from Primed Pluripotent Stem Cells. Stem Cell Reports. 2019 09 10; 13(3):485-498. Kime C, Kiyonari H, Ohtsuka S, Kohbayashi E, Asahi M, Yamanaka S, Takahashi M, Tomoda K. PMID: 31402336.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    5. Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I. Stem Cell Res. 2019 04; 36:101406. Suga M, Kondo T, Imamura K, Shibukawa R, Okanishi Y, Sagara Y, Tsukita K, Enami T, Furujo M, Saijo K, Nakamura Y, Osawa M, Saito MK, Yamanaka S, Inoue H. PMID: 30849633.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Application of induced pluripotent stem cells to primary immunodeficiency diseases. Exp Hematol. 2019 03; 71:43-50. Karagiannis P, Yamanaka S, Saito MK. PMID: 30664903.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    7. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development. Physiol Rev. 2019 01 01; 99(1):79-114. Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, Inoue H, Yamashita JK, Todani M, Nakagawa M, Osawa M, Yashiro Y, Yamanaka S, Osafune K. PMID: 30328784.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    8. Concise Review: Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury. Stem Cells. 2019 01; 37(1):6-13. Tsuji O, Sugai K, Yamaguchi R, Tashiro S, Nagoshi N, Kohyama J, Iida T, Ohkubo T, Itakura G, Isoda M, Shinozaki M, Fujiyoshi K, Kanemura Y, Yamanaka S, Nakamura M, Okano H. PMID: 30371964.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    9. MYC Releases Early Reprogrammed Human Cells from Proliferation Pause via Retinoblastoma Protein Inhibition. Cell Rep. 2018 Apr 10; 23(2):361-375. Rand TA, Sutou K, Tanabe K, Jeong D, Nomura M, Kitaoka F, Tomoda E, Narita M, Nakamura M, Nakamura M, Watanabe A, Rulifson E, Yamanaka S, Takahashi K. PMID: 29641997.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    10. Structural and spatial chromatin features at developmental gene loci in human pluripotent stem cells. Nat Commun. 2017 11 20; 8(1):1616. Ikeda H, Sone M, Yamanaka S, Yamamoto T. PMID: 29158493.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    11. Epigenetic foundations of pluripotent stem cells that recapitulate in vivo pluripotency. Lab Invest. 2017 10; 97(10):1133-1141. Yagi M, Yamanaka S, Yamada Y. PMID: 28869587.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    12. MHC matching improves engraftment of iPSC-derived neurons in non-human primates. Nat Commun. 2017 08 30; 8(1):385. Morizane A, Kikuchi T, Hayashi T, Mizuma H, Takara S, Doi H, Mawatari A, Glasser MF, Shiina T, Ishigaki H, Itoh Y, Okita K, Yamasaki E, Doi D, Onoe H, Ogasawara K, Yamanaka S, Takahashi J. PMID: 28855509.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    13. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model. Sci Rep. 2017 08 18; 7(1):8824. Kawamura M, Miyagawa S, Fukushima S, Saito A, Miki K, Funakoshi S, Yoshida Y, Yamanaka S, Shimizu T, Okano T, Daimon T, Toda K, Sawa Y. PMID: 28821761.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    14. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications. Circ Res. 2017 Jun 09; 120(12):1958-1968. Yoshida Y, Yamanaka S. PMID: 28596174.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    15. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med. 2017 05 24; 9(391). Imamura K, Izumi Y, Watanabe A, Tsukita K, Woltjen K, Yamamoto T, Hotta A, Kondo T, Kitaoka S, Ohta A, Tanaka A, Watanabe D, Morita M, Takuma H, Tamaoka A, Kunath T, Wray S, Furuya H, Era T, Makioka K, Okamoto K, Fujisawa T, Nishitoh H, Homma K, Ichijo H, Julien JP, Obata N, Hosokawa M, Akiyama H, Kaneko S, Ayaki T, Ito H, Kaji R, Takahashi R, Yamanaka S, Inoue H. PMID: 28539470.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    16. Hybrid Cellular Metabolism Coordinated by Zic3 and Esrrb Synergistically Enhances Induction of Naive Pluripotency. Cell Metab. 2017 May 02; 25(5):1103-1117.e6. Sone M, Morone N, Nakamura T, Tanaka A, Okita K, Woltjen K, Nakagawa M, Heuser JE, Yamada Y, Yamanaka S, Yamamoto T. PMID: 28467928.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    17. New Models for Therapeutic Innovation from Japan. EBioMedicine. 2017 04; 18:3-4. Karagiannis P, Onodera A, Yamanaka S. PMID: 28377227.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    18. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med. 2017 03 16; 376(11):1038-1046. Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, Go MJ, Shinohara C, Hata KI, Sawada M, Yamamoto M, Ohta S, Ohara Y, Yoshida K, Kuwahara J, Kitano Y, Amano N, Umekage M, Kitaoka F, Tanaka A, Okada C, Takasu N, Ogawa S, Yamanaka S, Takahashi M. PMID: 28296613.
      View in: PubMed   Mentions: 202     Fields:    Translation:HumansCells
    19. Nat1 promotes translation of specific proteins that induce differentiation of mouse embryonic stem cells. Proc Natl Acad Sci U S A. 2017 01 10; 114(2):340-345. Sugiyama H, Takahashi K, Yamamoto T, Iwasaki M, Narita M, Nakamura M, Rand TA, Nakagawa M, Watanabe A, Yamanaka S. PMID: 28003464.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    20. Induced pluripotent stem cell technology: a decade of progress. Nat Rev Drug Discov. 2017 02; 16(2):115-130. Shi Y, Inoue H, Wu JC, Yamanaka S. PMID: 27980341.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansCells
    21. BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proc Natl Acad Sci U S A. 2016 11 15; 113(46):13057-13062. Hayashi Y, Hsiao EC, Sami S, Lancero M, Schlieve CR, Nguyen T, Yano K, Nagahashi A, Ikeya M, Matsumoto Y, Nishimura K, Fukuda A, Hisatake K, Tomoda K, Asaka I, Toguchida J, Conklin BR, Yamanaka S. PMID: 27794120.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    22. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PLoS One. 2016; 11(10):e0164795. Sasaki K, Makiyama T, Yoshida Y, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Kawamura M, Ohno S, Itoh H, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T. PMID: 27764147.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    23. Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program. Proc Natl Acad Sci U S A. 2016 11 01; 113(44):12478-12483. Kime C, Sakaki-Yumoto M, Goodrich L, Hayashi Y, Sami S, Derynck R, Asahi M, Panning B, Yamanaka S, Tomoda K. PMID: 27738243.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    24. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Sci Rep. 2016 09 09; 6:32532. Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H. PMID: 27608814.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    25. Epigenetic Variation between Human Induced Pluripotent Stem Cell Lines Is an Indicator of Differentiation Capacity. Cell Stem Cell. 2016 09 01; 19(3):341-54. Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A, Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M, Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y. PMID: 27476965.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    26. Identification of MMP1 as a novel risk factor for intracranial aneurysms in ADPKD using iPSC models. Sci Rep. 2016 07 15; 6:30013. Ameku T, Taura D, Sone M, Numata T, Nakamura M, Shiota F, Toyoda T, Matsui S, Araoka T, Yasuno T, Mae S, Kobayashi H, Kondo N, Kitaoka F, Amano N, Arai S, Ichisaka T, Matsuura N, Inoue S, Yamamoto T, Takahashi K, Asaka I, Yamada Y, Ubara Y, Muso E, Fukatsu A, Watanabe A, Sato Y, Nakahata T, Mori Y, Koizumi A, Nakao K, Yamanaka S, Osafune K. PMID: 27418197.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    27. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency. Stem Cells. 2016 11; 34(11):2661-2669. Yamakawa T, Sato Y, Matsumura Y, Kobayashi Y, Kawamura Y, Goshima N, Yamanaka S, Okita K. PMID: 27335261.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    28. Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins. Stem Cells Int. 2016; 2016:7235757. Fukusumi H, Shofuda T, Bamba Y, Yamamoto A, Kanematsu D, Handa Y, Okita K, Nakamura M, Yamanaka S, Okano H, Kanemura Y. PMID: 27212953.
      View in: PubMed   Mentions:
    29. When Myc's asleep, embryonic stem cells are dormant. EMBO J. 2016 Apr 15; 35(8):801-2. Nakagawa M, Karagiannis P, Yamanaka S. PMID: 26968984.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    30. SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells. Elife. 2016 Mar 07; 5:e10647. Myers SA, Peddada S, Chatterjee N, Friedrich T, Tomoda K, Krings G, Thomas S, Maynard J, Broeker M, Thomson M, Pollard K, Yamanaka S, Burlingame AL, Panning B. PMID: 26949256.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    31. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies. Regen Ther. 2016 Jun; 4:36-47. Azuma K, Yamanaka S. PMID: 31245486.
      View in: PubMed   Mentions:
    32. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016 Mar; 17(3):183-93. Takahashi K, Yamanaka S. PMID: 26883003.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansAnimals
    33. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep. 2016 Jan 08; 6:19111. Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y. PMID: 26743035.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    34. Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons. Methods Mol Biol. 2016; 1357:111-31. Kim SI, Oceguera-Yanez F, Sakurai C, Nakagawa M, Yamanaka S, Woltjen K. PMID: 26025620.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    35. Efficient CRISPR/Cas9-Based Genome Engineering in Human Pluripotent Stem Cells. Curr Protoc Hum Genet. 2016 Jan 01; 88:21.4.1-21.4.23. Kime C, Mandegar MA, Srivastava D, Yamanaka S, Conklin BR, Rand TA. PMID: 26724721.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    36. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells. Regen Ther. 2015 Dec; 2:95-108. Hayakawa T, Aoi T, Umezawa A, Ozawa K, Sato Y, Sawa Y, Matsuyama A, Yamanaka S, Yamato M. PMID: 31245463.
      View in: PubMed   Mentions:
    37. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells. Regen Ther. 2015 Dec; 2:57-69. Hayakawa T, Aoi T, Umezawa A, Ozawa K, Sato Y, Sawa Y, Matsuyama A, Yamanaka S, Yamato M. PMID: 31245460.
      View in: PubMed   Mentions:
    38. A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells. Regen Ther. 2015 Dec; 2:81-94. Hayakawa T, Aoi T, Umezawa A, Ozawa K, Sato Y, Sawa Y, Matsuyama A, Yamanaka S, Yamato M. PMID: 31245462.
      View in: PubMed   Mentions:
    39. Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells. Curr Protoc Hum Genet. 2015 Oct 06; 87:21.2.1-21.2.21. Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K. PMID: 26439714.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    40. A developmental framework for induced pluripotency. Development. 2015 Oct 01; 142(19):3274-85. Takahashi K, Yamanaka S. PMID: 26443632.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    41. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing. Annu Rev Genet. 2015; 49:47-70. Hotta A, Yamanaka S. PMID: 26407033.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    42. Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice. Stem Cells Transl Med. 2015 Sep; 4(9):980-92. Toyohara T, Mae S, Sueta S, Inoue T, Yamagishi Y, Kawamoto T, Kasahara T, Hoshina A, Toyoda T, Tanaka H, Araoka T, Sato-Otsubo A, Takahashi K, Sato Y, Yamaji N, Ogawa S, Yamanaka S, Osafune K. PMID: 26198166.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    43. Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells. Cell Stem Cell. 2015 Aug 06; 17(2):178-94. Sasaki K, Yokobayashi S, Nakamura T, Okamoto I, Yabuta Y, Kurimoto K, Ohta H, Moritoki Y, Iwatani C, Tsuchiya H, Nakamura S, Sekiguchi K, Sakuma T, Yamamoto T, Mori T, Woltjen K, Nakagawa M, Yamamoto T, Takahashi K, Yamanaka S, Saitou M. PMID: 26189426.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimalsCells
    44. Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches. Cell Stem Cell. 2015 Jun 04; 16(6):699-711. Miki K, Endo K, Takahashi S, Funakoshi S, Takei I, Katayama S, Toyoda T, Kotaka M, Takaki T, Umeda M, Okubo C, Nishikawa M, Oishi A, Narita M, Miyashita I, Asano K, Hayashi K, Osafune K, Yamanaka S, Saito H, Yoshida Y. PMID: 26004781.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimalsCells
    45. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications. Circ Res. 2015 Apr 10; 116(8):1378-91. Sadahiro T, Yamanaka S, Ieda M. PMID: 25858064.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    46. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Proc Natl Acad Sci U S A. 2015 Apr 14; 112(15):4666-71. Hayashi Y, Caboni L, Das D, Yumoto F, Clayton T, Deller MC, Nguyen P, Farr CL, Chiu HJ, Miller MD, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Tomoda K, Conklin BR, Wilson IA, Yamanaka S, Fletterick RJ. PMID: 25825768.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    47. KLF4 N-terminal variance modulates induced reprogramming to pluripotency. Stem Cell Reports. 2015 Apr 14; 4(4):727-43. Kim SI, Oceguera-Yanez F, Hirohata R, Linker S, Okita K, Yamada Y, Yamamoto T, Yamanaka S, Woltjen K. PMID: 25772473.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    48. Development of a global network of induced pluripotent stem cell haplobanks. Regen Med. 2015; 10(3):235-8. Wilmut I, Leslie S, Martin NG, Peschanski M, Rao M, Trounson A, Turner D, Turner ML, Yamanaka S, Taylor CJ. PMID: 25933231.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    49. The homeobox gene DLX4 promotes generation of human induced pluripotent stem cells. Sci Rep. 2014 Dec 04; 4:7283. Tamaoki N, Takahashi K, Aoki H, Iida K, Kawaguchi T, Hatakeyama D, Inden M, Chosa N, Ishisaki A, Kunisada T, Shibata T, Goshima N, Yamanaka S, Tezuka K. PMID: 25471527.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    50. Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Reports. 2015 Jan 13; 4(1):143-154. Li HL, Fujimoto N, Sasakawa N, Shirai S, Ohkame T, Sakuma T, Tanaka M, Amano N, Watanabe A, Sakurai H, Yamamoto T, Yamanaka S, Hotta A. PMID: 25434822.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansCells
    51. Computational image analysis of colony and nuclear morphology to evaluate human induced pluripotent stem cells. Sci Rep. 2014 Nov 11; 4:6996. Tokunaga K, Saitoh N, Goldberg IG, Sakamoto C, Yasuda Y, Yoshida Y, Yamanaka S, Nakao M. PMID: 25385348.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    52. The fate of cell reprogramming. Nat Methods. 2014 Oct; 11(10):1006-8. Karagiannis P, Yamanaka S. PMID: 25264776.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    53. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential. Proc Natl Acad Sci U S A. 2014 Aug 26; 111(34):12426-31. Ohnuki M, Tanabe K, Sutou K, Teramoto I, Sawamura Y, Narita M, Nakamura M, Tokunaga Y, Nakamura M, Watanabe A, Yamanaka S, Takahashi K. PMID: 25097266.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    54. Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol. 2014 Aug; 32(8):724-6. Andrews PW, Cavagnaro J, Cavanagro J, Deans R, Feigal E, Feigel E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S. PMID: 25093882.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    55. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. Stem Cell Reports. 2014 Aug 12; 3(2):269-81. Spencer CI, Baba S, Nakamura K, Hua EA, Sears MA, Fu CC, Zhang J, Balijepalli S, Tomoda K, Hayashi Y, Lizarraga P, Wojciak J, Scheinman MM, Aalto-Setälä K, Makielski JC, January CT, Healy KE, Kamp TJ, Yamanaka S, Conklin BR. PMID: 25254341.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    56. Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports. 2014 Aug 12; 3(2):242-9. Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M, Takahashi R, Okano H, Yamanaka S, Inoue H. PMID: 25254338.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    57. Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm. Nat Commun. 2014 Apr 24; 5:3678. Takahashi K, Tanabe K, Ohnuki M, Narita M, Sasaki A, Yamamoto M, Nakamura M, Sutou K, Osafune K, Yamanaka S. PMID: 24759836.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    58. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Reports. 2014 May 06; 2(5):648-61. Numasawa-Kuroiwa Y, Okada Y, Shibata S, Kishi N, Akamatsu W, Shoji M, Nakanishi A, Oyama M, Osaka H, Inoue K, Takahashi K, Yamanaka S, Kosaki K, Takahashi T, Okano H. PMID: 24936452.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    59. Generation and characterization of induced pluripotent stem cells from Aid-deficient mice. PLoS One. 2014; 9(4):e94735. Shimamoto R, Amano N, Ichisaka T, Watanabe A, Yamanaka S, Okita K. PMID: 24718089.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    60. A chemical probe that labels human pluripotent stem cells. Cell Rep. 2014 Mar 27; 6(6):1165-1174. Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato SI, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase E, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi M. PMID: 24613351.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    61. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell. 2014 Feb 13; 156(4):663-77. Ohnishi K, Semi K, Yamamoto T, Shimizu M, Tanaka A, Mitsunaga K, Okita K, Osafune K, Arioka Y, Maeda T, Soejima H, Moriwaki H, Yamanaka S, Woltjen K, Yamada Y. PMID: 24529372.
      View in: PubMed   Mentions: 116     Fields:    Translation:AnimalsCells
    62. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell. 2014 Apr 03; 14(4):535-48. Nakamura S, Takayama N, Hirata S, Seo H, Endo H, Ochi K, Fujita K, Koike T, Harimoto K, Dohda T, Watanabe A, Okita K, Takahashi N, Sawaguchi A, Yamanaka S, Nakauchi H, Nishimura S, Eto K. PMID: 24529595.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    63. iPS cells: a game changer for future medicine. EMBO J. 2014 Mar 03; 33(5):409-17. Inoue H, Nagata N, Kurokawa H, Yamanaka S. PMID: 24500035.
      View in: PubMed   Mentions: 122     Fields:    Translation:HumansCells
    64. Perspectives for induced pluripotent stem cell technology: new insights into human physiology involved in somatic mosaicism. Circ Res. 2014 Jan 31; 114(3):505-10. Nagata N, Yamanaka S. PMID: 24481841.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    65. Efficient and rapid induction of human iPSCs/ESCs into nephrogenic intermediate mesoderm using small molecule-based differentiation methods. PLoS One. 2014; 9(1):e84881. Araoka T, Mae S, Kurose Y, Uesugi M, Ohta A, Yamanaka S, Osafune K. PMID: 24454758.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    66. Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature. 2014 Mar 06; 507(7490):99-103. Bershteyn M, Hayashi Y, Desachy G, Hsiao EC, Sami S, Tsang KM, Weiss LA, Kriegstein AR, Yamanaka S, Wynshaw-Boris A. PMID: 24413397.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    67. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep. 2014 Jan 08; 4:3594. Nakagawa M, Taniguchi Y, Senda S, Takizawa N, Ichisaka T, Asano K, Morizane A, Doi D, Takahashi J, Nishizawa M, Yoshida Y, Toyoda T, Osafune K, Sekiguchi K, Yamanaka S. PMID: 24399248.
      View in: PubMed   Mentions: 124     Fields:    Translation:HumansCells
    68. Induction of pluripotency by defined factors. Proc Jpn Acad Ser B Phys Biol Sci. 2014; 90(3):83-96. Tanabe K, Takahashi K, Yamanaka S. PMID: 24621955.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    69. Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis. 2013 Dec 09; 8:190. Matsumoto Y, Hayashi Y, Schlieve CR, Ikeya M, Kim H, Nguyen TD, Sami S, Baba S, Barruet E, Nasu A, Asaka I, Otsuka T, Yamanaka S, Conklin BR, Toguchida J, Hsiao EC. PMID: 24321451.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    70. Tsix RNA and the germline factor, PRDM14, link X reactivation and stem cell reprogramming. Mol Cell. 2013 Dec 26; 52(6):805-18. Payer B, Rosenberg M, Yamaji M, Yabuta Y, Koyanagi-Aoi M, Hayashi K, Yamanaka S, Saitou M, Lee JT. PMID: 24268575.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    71. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc Natl Acad Sci U S A. 2013 Dec 17; 110(51):20569-74. Koyanagi-Aoi M, Ohnuki M, Takahashi K, Okita K, Noma H, Sawamura Y, Teramoto I, Narita M, Sato Y, Ichisaka T, Amano N, Watanabe A, Morizane A, Yamada Y, Sato T, Takahashi J, Yamanaka S. PMID: 24259714.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansAnimalsCells
    72. The winding road to pluripotency (Nobel Lecture). Angew Chem Int Ed Engl. 2013 Dec 23; 52(52):13900-9. Yamanaka S. PMID: 24255017.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    73. The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. Cell Stem Cell. 2014 Jan 02; 14(1):40-52. Worringer KA, Rand TA, Hayashi Y, Sami S, Takahashi K, Tanabe K, Narita M, Srivastava D, Yamanaka S. PMID: 24239284.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    74. Global splicing pattern reversion during somatic cell reprogramming. Cell Rep. 2013 Oct 31; 5(2):357-66. Ohta S, Nishida E, Yamanaka S, Yamamoto T. PMID: 24139801.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    75. Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell. 2013 Oct 03; 13(4):382-4. Turner M, Leslie S, Martin NG, Peschanski M, Rao M, Taylor CJ, Trounson A, Turner D, Yamanaka S, Wilmut I. PMID: 24094319.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    76. Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate. Stem Cell Reports. 2013; 1(4):283-92. Morizane A, Doi D, Kikuchi T, Okita K, Hotta A, Kawasaki T, Hayashi T, Onoe H, Shiina T, Yamanaka S, Takahashi J. PMID: 24319664.
      View in: PubMed   Mentions: 78     Fields:    Translation:AnimalsCells
    77. Tudor domain containing 12 (TDRD12) is essential for secondary PIWI interacting RNA biogenesis in mice. Proc Natl Acad Sci U S A. 2013 Oct 08; 110(41):16492-7. Pandey RR, Tokuzawa Y, Yang Z, Hayashi E, Ichisaka T, Kajita S, Asano Y, Kunieda T, Sachidanandam R, Chuma S, Yamanaka S, Pillai RS. PMID: 24067652.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    78. Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc Natl Acad Sci U S A. 2013 Jul 23; 110(30):12172-9. Tanabe K, Nakamura M, Narita M, Takahashi K, Yamanaka S. PMID: 23812749.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    79. Making steady progress on direct cardiac reprogramming toward clinical application. Circ Res. 2013 Jun 21; 113(1):13-5. Miki K, Yoshida Y, Yamanaka S. PMID: 23788502.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    80. Response to comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci Transl Med. 2013 Jun 05; 5(188):188lr2. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H. PMID: 23740898.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    81. Induced pluripotent stem cells in medicine and biology. Development. 2013 Jun; 140(12):2457-61. Takahashi K, Yamanaka S. PMID: 23715538.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    82. To be immunogenic, or not to be: that's the iPSC question. Cell Stem Cell. 2013 Apr 04; 12(4):385-6. Kaneko S, Yamanaka S. PMID: 23561437.
      View in: PubMed   Mentions: 23     Fields:    
    83. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013 Mar; 31(3):458-66. Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, Goshima N, Yamanaka S. PMID: 23193063.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCells
    84. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aß and differential drug responsiveness. Cell Stem Cell. 2013 Apr 04; 12(4):487-96. Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H. PMID: 23434393.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCells
    85. Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J. 2013; 77(5):1307-14. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, Chen J, Hattori T, Ohno S, Kita T, Horie M, Yamanaka S, Kimura T. PMID: 23400258.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    86. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res. 2013 Feb 01; 112(3):523-33. Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, Miura K. PMID: 23371901.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansAnimalsCells
    87. Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo. J Invest Dermatol. 2013 Jun; 133(6):1479-88. Veraitch O, Kobayashi T, Imaizumi Y, Akamatsu W, Sasaki T, Yamanaka S, Amagai M, Okano H, Ohyama M. PMID: 23321923.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    88. Epigenetic regulation in pluripotent stem cells: a key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci. 2013 Jan 05; 368(1609):20120292. Watanabe A, Yamada Y, Yamanaka S. PMID: 23166402.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    89. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat Commun. 2013; 4:1367. Mae SI, Shono A, Shiota F, Yasuno T, Kajiwara M, Gotoda-Nishimura N, Arai S, Sato-Otubo A, Toyoda T, Takahashi K, Nakayama N, Cowan CA, Aoi T, Ogawa S, McMahon AP, Yamanaka S, Osafune K. PMID: 23340407.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansAnimalsCells
    90. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells. Sci Rep. 2013; 3:1978. Yamashita A, Liu S, Woltjen K, Thomas B, Meng G, Hotta A, Takahashi K, Ellis J, Yamanaka S, Rancourt DE. PMID: 23760219.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    91. Shinya Yamanaka: purveyor of pluripotency. Interview by Ruth Williams. Circ Res. 2013 Jan 18; 112(2):233-5. Yamanaka S. PMID: 23233755.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    92. Rapid and deep profiling of human induced pluripotent stem cell proteome by one-shot NanoLC-MS/MS analysis with meter-scale monolithic silica columns. J Proteome Res. 2013 Jan 04; 12(1):214-21. Yamana R, Iwasaki M, Wakabayashi M, Nakagawa M, Yamanaka S, Ishihama Y. PMID: 23210603.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    93. Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. Stem Cells Dev. 2013 Feb 01; 22(3):473-82. Fujishiro SH, Nakano K, Mizukami Y, Azami T, Arai Y, Matsunari H, Ishino R, Nishimura T, Watanabe M, Abe T, Furukawa Y, Umeyama K, Yamanaka S, Ema M, Nagashima H, Hanazono Y. PMID: 22889279.
      View in: PubMed   Mentions: 49     Fields:    Translation:AnimalsCells
    94. Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012 Aug 01; 4(145):145ra104. Egawa N, Kitaoka S, Tsukita K, Naitoh M, Takahashi K, Yamamoto T, Adachi F, Kondo T, Okita K, Asaka I, Aoi T, Watanabe A, Yamada Y, Morizane A, Takahashi J, Ayaki T, Ito H, Yoshikawa K, Yamawaki S, Suzuki S, Watanabe D, Hioki H, Kaneko T, Makioka K, Okamoto K, Takuma H, Tamaoka A, Hasegawa K, Nonaka T, Hasegawa M, Kawata A, Yoshida M, Nakahata T, Takahashi R, Marchetto MC, Gage FH, Yamanaka S, Inoue H. PMID: 22855461.
      View in: PubMed   Mentions: 168     Fields:    Translation:HumansCells
    95. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012 Jul 31; 109(31):12538-43. Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N, Endo H, Eto K, Toguchida J, Uemoto S, Yamanaka S. PMID: 22802639.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCellsCTClinical Trials
    96. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell. 2012 Jul 06; 11(1):91-9. Tomoda K, Takahashi K, Leung K, Okada A, Narita M, Yamada NA, Eilertson KE, Tsang P, Baba S, White MP, Sami S, Srivastava D, Conklin BR, Panning B, Yamanaka S. PMID: 22770243.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    97. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood. 2012 Aug 09; 120(6):1299-308. Tanaka T, Takahashi K, Yamane M, Tomida S, Nakamura S, Oshima K, Niwa A, Nishikomori R, Kambe N, Hara H, Mitsuyama M, Morone N, Heuser JE, Yamamoto T, Watanabe A, Sato-Otsubo A, Ogawa S, Asaka I, Heike T, Yamanaka S, Nakahata T, Saito MK. PMID: 22723549.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    98. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012 Jun 14; 10(6):678-684. Yamanaka S. PMID: 22704507.
      View in: PubMed   Mentions: 218     Fields:    Translation:HumansAnimalsCells
    99. Stem cells assessed. Nat Rev Mol Cell Biol. 2012 06 08; 13(7):471-6. Blanpain C, Daley GQ, Hochedlinger K, Passegué E, Rossant J, Yamanaka S. PMID: 22678486.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    100. Germline development from human pluripotent stem cells toward disease modeling of infertility. Fertil Steril. 2012 Jun; 97(6):1250-9. Hayashi Y, Saitou M, Yamanaka S. PMID: 22656305.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    101. Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med. 2012 May; 1(5):430-7. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, Higuchi T, Shimizu T, Okano T, Yamanaka S, Sawa Y. PMID: 23197822.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    102. [Research for cell therapy by induced pluripotent stem cell]. Nihon Rinsho. 2011 Dec; 69(12):2114-8. Sakurai H, Yamanaka S. PMID: 22242307.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    103. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011 Nov 27; 29(12):1132-44. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, De Sousa PA, Denning C, Downie J, Dvorak P, Montgomery KD, Feki A, Ford A, Fox V, Fraga AM, Frumkin T, Ge L, Gokhale PJ, Golan-Lev T, Gourabi H, Gropp M, Lu G, Hampl A, Harron K, Healy L, Herath W, Holm F, Hovatta O, Hyllner J, Inamdar MS, Irwanto AK, Ishii T, Jaconi M, Jin Y, Kimber S, Kiselev S, Knowles BB, Kopper O, Kukharenko V, Kuliev A, Lagarkova MA, Laird PW, Lako M, Laslett AL, Lavon N, Lee DR, Lee JE, Li C, Lim LS, Ludwig TE, Ma Y, Maltby E, Mateizel I, Mayshar Y, Mileikovsky M, Minger SL, Miyazaki T, Moon SY, Moore H, Mummery C, Nagy A, Nakatsuji N, Narwani K, Oh SK, Oh SK, Olson C, Otonkoski T, Pan F, Park IH, Pells S, Pera MF, Pereira LV, Qi O, Raj GS, Reubinoff B, Robins A, Robson P, Rossant J, Salekdeh GH, Schulz TC, Sermon K, Sheik Mohamed J, Shen H, Sherrer E, Sidhu K, Sivarajah S, Skottman H, Spits C, Stacey GN, Strehl R, Strelchenko N, Suemori H, Sun B, Suuronen R, Takahashi K, Tuuri T, Venu P, Verlinsky Y, Ward-van Oostwaard D, Weisenberger DJ, Wu Y, Yamanaka S, Young L, Zhou Q. PMID: 22119741.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCells
    104. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture. Dis Model Mech. 2012 Mar; 5(2):220-30. Lahti AL, Kujala VJ, Chapman H, Koivisto AP, Pekkanen-Mattila M, Kerkelä E, Hyttinen J, Kontula K, Swan H, Conklin BR, Yamanaka S, Silvennoinen O, Aalto-Setälä K. PMID: 22052944.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansCells
    105. Glis1, a unique pro-reprogramming factor, may facilitate clinical applications of iPSC technology. . 2011 Nov 01; 10(21):3613-4. Maekawa M, Yamanaka S. PMID: 22033139.
      View in: PubMed   Mentions:
    106. Integration-free iPS cells engineered using human artificial chromosome vectors. PLoS One. 2011; 6(10):e25961. Hiratsuka M, Uno N, Ueda K, Kurosaki H, Imaoka N, Kazuki K, Ueno E, Akakura Y, Katoh M, Osaki M, Kazuki Y, Nakagawa M, Yamanaka S, Oshimura M. PMID: 21998730.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    107. Anti-Aß drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One. 2011; 6(9):e25788. Yahata N, Asai M, Kitaoka S, Takahashi K, Asaka I, Hioki H, Kaneko T, Maruyama K, Saido TC, Nakahata T, Asada T, Yamanaka S, Iwata N, Inoue H. PMID: 21984949.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansCells
    108. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci U S A. 2011 Oct 04; 108(40):16825-30. Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, Kobayashi Y, Fujiyoshi K, Koike M, Uchiyama Y, Ikeda E, Toyama Y, Yamanaka S, Nakamura M, Okano H. PMID: 21949375.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansAnimalsCells
    109. Immunogenicity of induced pluripotent stem cells. Circ Res. 2011 Sep 16; 109(7):720-1. Okita K, Nagata N, Yamanaka S. PMID: 21921270.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    110. Modeling familial Alzheimer's disease with induced pluripotent stem cells. Hum Mol Genet. 2011 Dec 01; 20(23):4530-9. Yagi T, Ito D, Okada Y, Akamatsu W, Nihei Y, Yoshizaki T, Yamanaka S, Okano H, Suzuki N. PMID: 21900357.
      View in: PubMed   Mentions: 188     Fields:    Translation:HumansAnimalsCells
    111. Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Res. 2011 Nov; 21(11):1551-63. Wang YC, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite RM, Nazor KL, Tran HT, Lynch CL, Leonardo TR, Liu Y, Peterson SE, Laurent LC, Yamanaka S, Loring JF. PMID: 21894191.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    112. Essential roles of ECAT15-2/Dppa2 in functional lung development. Mol Cell Biol. 2011 Nov; 31(21):4366-78. Nakamura T, Nakagawa M, Ichisaka T, Shiota A, Yamanaka S. PMID: 21896782.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    113. Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression. PLoS One. 2011; 6(8):e23657. Uosaki H, Fukushima H, Takeuchi A, Matsuoka S, Nakatsuji N, Yamanaka S, Yamashita JK. PMID: 21876760.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCells
    114. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci. 2011 Aug 12; 366(1575):2198-207. Okita K, Yamanaka S. PMID: 21727125.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCells
    115. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature. 2011 Jun 08; 474(7350):225-9. Maekawa M, Yamaguchi K, Nakamura T, Shibukawa R, Kodanaka I, Ichisaka T, Kawamura Y, Mochizuki H, Goshima N, Yamanaka S. PMID: 21654807.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansAnimalsCells
    116. The nomenclature system should be sustainable, but also practical. Cell Stem Cell. 2011 Jun 03; 8(6):606-7. Higashi H, Brüstle O, Daley GQ, Yamanaka S. PMID: 21624802.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    117. ECAT11/L1td1 is enriched in ESCs and rapidly activated during iPSC generation, but it is dispensable for the maintenance and induction of pluripotency. PLoS One. 2011; 6(5):e20461. Iwabuchi KA, Yamakawa T, Sato Y, Ichisaka T, Takahashi K, Okita K, Yamanaka S. PMID: 21637830.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    118. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011 May; 8(5):409-12. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S. PMID: 21460823.
      View in: PubMed   Mentions: 570     Fields:    Translation:HumansCells
    119. Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One. 2011 Feb 22; 6(2):e16734. Fujiwara M, Yan P, Otsuji TG, Narazaki G, Uosaki H, Fukushima H, Kuwahara K, Harada M, Matsuda H, Matsuoka S, Okita K, Takahashi K, Nakagawa M, Ikeda T, Sakata R, Mummery CL, Nakatsuji N, Yamanaka S, Nakao K, Yamashita JK. PMID: 21364991.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    120. Genome-sequencing anniversary. Of mice and humans. Science. 2011 Feb 18; 331(6019):873. Yamanaka S. PMID: 21330532.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    121. Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011 Jan 13; 6(1):e16182. Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y. PMID: 21249204.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    122. Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med. 2010 Dec 20; 207(13):2817-30. Takayama N, Nishimura S, Nakamura S, Shimizu T, Ohnishi R, Endo H, Yamaguchi T, Otsu M, Nishimura K, Nakanishi M, Sawaguchi A, Nagai R, Takahashi K, Yamanaka S, Nakauchi H, Eto K. PMID: 21098095.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimalsCells
    123. [Derivation of engraftable myogenic precursors from murine ES/iPS cells and generation of disease-specific iPS cells from patients with Duchenne muscular dystrophy (DMD) and other diseases]. Rinsho Shinkeigaku. 2010 Nov; 50(11):889. Nakahata T, Awaya T, Chang H, Mizuno Y, Niwa A, Fukada S, Takeda S, Yamanaka S, Heike T. PMID: 21921492.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    124. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol. 2011 Feb; 50(2):327-32. Yoshida Y, Yamanaka S. PMID: 21040726.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    125. Gingival fibroblasts as a promising source of induced pluripotent stem cells. PLoS One. 2010 Sep 14; 5(9):e12743. Egusa H, Okita K, Kayashima H, Yu G, Fukuyasu S, Saeki M, Matsumoto T, Yamanaka S, Yatani H. PMID: 20856871.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    126. Induction of primordial germ cells from mouse induced pluripotent stem cells derived from adult hepatocytes. Mol Reprod Dev. 2010 Sep; 77(9):802-11. Imamura M, Aoi T, Tokumasu A, Mise N, Abe K, Yamanaka S, Noce T. PMID: 20722049.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    127. Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest. 2010 Sep; 120(9):3120-6. Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, Okita K, Yamanaka S, Willenbring H. PMID: 20739754.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    128. Promotion of direct reprogramming by transformation-deficient Myc. Proc Natl Acad Sci U S A. 2010 Aug 10; 107(32):14152-7. Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S. PMID: 20660764.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansAnimalsCells
    129. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010 Jul 13; 107(28):12704-9. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, Nagoshi N, Kitamura K, Kumagai G, Nishino M, Tomisato S, Higashi H, Nagai T, Katoh H, Kohda K, Matsuzaki Y, Yuzaki M, Ikeda E, Toyama Y, Nakamura M, Yamanaka S, Okano H. PMID: 20615974.
      View in: PubMed   Mentions: 157     Fields:    Translation:AnimalsCells
    130. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation. 2010 Jul 06; 122(1):80-7. Yoshida Y, Yamanaka S. PMID: 20606130.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCells
    131. Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell. 2010 Jul 02; 7(1):1-2. Yamanaka S. PMID: 20621038.
      View in: PubMed   Mentions: 17     Fields:    
    132. miRNAs regulate SIRT1 expression during mouse embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY). 2010 Jul; 2(7):415-31. Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, Verdin E. PMID: 20634564.
      View in: PubMed   Mentions: 102     Fields:    Translation:AnimalsCells
    133. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res. 2010 Nov 01; 88(2):314-23. Kaichi S, Hasegawa K, Takaya T, Yokoo N, Mima T, Kawamura T, Morimoto T, Ono K, Baba S, Doi H, Yamanaka S, Nakahata T, Heike T. PMID: 20547733.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    134. Nuclear reprogramming to a pluripotent state by three approaches. Nature. 2010 Jun 10; 465(7299):704-12. Yamanaka S, Blau HM. PMID: 20535199.
      View in: PubMed   Mentions: 281     Fields:    Translation:HumansAnimalsCells
    135. Genome-wide DNA methylation profile of tissue-dependent and differentially methylated regions (T-DMRs) residing in mouse pluripotent stem cells. Genes Cells. 2010 Jun; 15(6):607-18. Sato S, Yagi S, Arai Y, Hirabayashi K, Hattori N, Iwatani M, Okita K, Ohgane J, Tanaka S, Wakayama T, Yamanaka S, Shiota K. PMID: 20477876.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    136. An interview with... Shinya Yamanaka. Interview by Mary Muers. Nat Rev Genet. 2010 Jun; 11(6):390. Yamanaka S. PMID: 20442716.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    137. Induction of pluripotency by defined factors. Exp Cell Res. 2010 Oct 01; 316(16):2565-70. Okita K, Yamanaka S. PMID: 20420827.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    138. Sirt1 plays an important role in mediating greater functionality of human ES/iPS-derived vascular endothelial cells. Atherosclerosis. 2010 Sep; 212(1):42-7. Homma K, Sone M, Taura D, Yamahara K, Suzuki Y, Takahashi K, Sonoyama T, Inuzuka M, Fukunaga Y, Tamura N, Itoh H, Yamanaka S, Nakao K. PMID: 20488443.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    139. Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells. FASEB J. 2010 Jul; 24(7):2245-53. Mizuno Y, Chang H, Umeda K, Niwa A, Iwasa T, Awaya T, Fukada S, Yamamoto H, Yamanaka S, Nakahata T, Heike T. PMID: 20181939.
      View in: PubMed   Mentions: 55     Fields:    Translation:AnimalsCells
    140. Generation of mouse-induced pluripotent stem cells with plasmid vectors. Nat Protoc. 2010 Mar; 5(3):418-28. Okita K, Hong H, Takahashi K, Yamanaka S. PMID: 20203661.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    141. Reprogramming of somatic cells to pluripotency. Adv Exp Med Biol. 2010; 695:215-24. Nakagawa M, Yamanaka S. PMID: 21222208.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    142. Complete genetic correction of ips cells from Duchenne muscular dystrophy. Mol Ther. 2010 Feb; 18(2):386-93. Kazuki Y, Hiratsuka M, Takiguchi M, Osaki M, Kajitani N, Hoshiya H, Hiramatsu K, Yoshino T, Kazuki K, Ishihara C, Takehara S, Higaki K, Nakagawa M, Takahashi K, Yamanaka S, Oshimura M. PMID: 19997091.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimalsCells
    143. Human induced pluripotent stem cells on autologous feeders. PLoS One. 2009 Dec 02; 4(12):e8067. Takahashi K, Narita M, Yokura M, Ichisaka T, Yamanaka S. PMID: 19956543.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    144. Efficient reprogramming of human and mouse primary extra-embryonic cells to pluripotent stem cells. Genes Cells. 2009 Dec; 14(12):1395-404. Nagata S, Toyoda M, Yamaguchi S, Hirano K, Makino H, Nishino K, Miyagawa Y, Okita H, Kiyokawa N, Nakagawa M, Yamanaka S, Akutsu H, Umezawa A, Tada T. PMID: 19912344.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    145. G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. PLoS One. 2009 Nov 10; 4(11):e7780. Nakamura K, Salomonis N, Tomoda K, Yamanaka S, Conklin BR. PMID: 19936228.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    146. Orderly hematopoietic development of induced pluripotent stem cells via Flk-1(+) hemoangiogenic progenitors. J Cell Physiol. 2009 Nov; 221(2):367-77. Niwa A, Umeda K, Chang H, Saito M, Okita K, Takahashi K, Nakagawa M, Yamanaka S, Nakahata T, Heike T. PMID: 19562687.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    147. Induced pluripotent stem cells and reprogramming: seeing the science through the hype. Nat Rev Genet. 2009 12; 10(12):878-83. Izpisúa Belmonte JC, Ellis J, Hochedlinger K, Yamanaka S. PMID: 19859062.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    148. Ekiden to iPS Cells. Nat Med. 2009 Oct; 15(10):1145-8. Yamanaka S. PMID: 19812575.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    149. Transplantation of mouse induced pluripotent stem cells into the cochlea. Neuroreport. 2009 Sep 23; 20(14):1250-4. Nishimura K, Nakagawa T, Ono K, Ogita H, Sakamoto T, Yamamoto N, Okita K, Yamanaka S, Ito J. PMID: 19625987.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    150. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009 Sep 04; 5(3):237-41. Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. PMID: 19716359.
      View in: PubMed   Mentions: 259     Fields:    Translation:HumansAnimalsCells
    151. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature. 2009 Aug 27; 460(7259):1132-5. Hong H, Takahashi K, Ichisaka T, Aoi T, Kanagawa O, Nakagawa M, Okita K, Yamanaka S. PMID: 19668191.
      View in: PubMed   Mentions: 559     Fields:    Translation:HumansAnimalsCells
    152. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Biophys Res Commun. 2009 Sep 25; 387(3):482-8. Yokoo N, Baba S, Kaichi S, Niwa A, Mima T, Doi H, Yamanaka S, Nakahata T, Heike T. PMID: 19615974.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    153. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009 Aug; 27(8):743-5. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. PMID: 19590502.
      View in: PubMed   Mentions: 301     Fields:    Translation:AnimalsCells
    154. Elite and stochastic models for induced pluripotent stem cell generation. Nature. 2009 Jul 02; 460(7251):49-52. Yamanaka S. PMID: 19571877.
      View in: PubMed   Mentions: 188     Fields:    Translation:HumansAnimalsCells
    155. Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol. 2009 Jun; Chapter 4:Unit 4A.2. Ohnuki M, Takahashi K, Yamanaka S. PMID: 19536759.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    156. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. Biochem Biophys Res Commun. 2009 Aug 07; 385(4):497-502. Tanaka T, Tohyama S, Murata M, Nomura F, Kaneko T, Chen H, Hattori F, Egashira T, Seki T, Ohno Y, Koshimizu U, Yuasa S, Ogawa S, Yamanaka S, Yasuda K, Fukuda K. PMID: 19464263.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    157. Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells. 2009 Jun; 14(6):683-94. Tsubooka N, Ichisaka T, Okita K, Takahashi K, Nakagawa M, Yamanaka S. PMID: 19476507.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    158. Induction and isolation of vascular cells from human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol. 2009 Jul; 29(7):1100-3. Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K. PMID: 19423866.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCells
    159. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells. 2009 May; 27(5):1021-31. Senju S, Haruta M, Matsunaga Y, Fukushima S, Ikeda T, Takahashi K, Okita K, Yamanaka S, Nishimura Y. PMID: 19415766.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    160. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett. 2009 Jul 24; 458(3):126-31. Hirami Y, Osakada F, Takahashi K, Okita K, Yamanaka S, Ikeda H, Yoshimura N, Takahashi M. PMID: 19379795.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansAnimalsCells
    161. A fresh look at iPS cells. Cell. 2009 Apr 03; 137(1):13-7. Yamanaka S. PMID: 19345179.
      View in: PubMed   Mentions: 249     Fields:    Translation:HumansAnimalsCells
    162. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell. 2009 Mar 06; 4(3):200-1; author reply 202. Daley GQ, Lensch MW, Jaenisch R, Meissner A, Plath K, Yamanaka S. PMID: 19265657.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    163. Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 2009 Mar 18; 583(6):1029-33. Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, Takahashi K, Homma K, Oyamada N, Inuzuka M, Sonoyama T, Ebihara K, Tamura N, Itoh H, Suemori H, Nakatsuji N, Okano H, Yamanaka S, Nakao K. PMID: 19250937.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    164. ERas is expressed in primate embryonic stem cells but not related to tumorigenesis. Cell Transplant. 2009; 18(4):381-9. Tanaka Y, Ikeda T, Kishi Y, Masuda S, Shibata H, Takeuchi K, Komura M, Iwanaka T, Muramatsu S, Kondo Y, Takahashi K, Yamanaka S, Hanazono Y. PMID: 19622226.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    165. Defining developmental potency and cell lineage trajectories by expression profiling of differentiating mouse embryonic stem cells. DNA Res. 2009 Feb; 16(1):73-80. Aiba K, Nedorezov T, Piao Y, Nishiyama A, Matoba R, Sharova LV, Sharov AA, Yamanaka S, Niwa H, Ko MS. PMID: 19112179.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    166. Subcutaneous phaeohyphomycosis caused by Exophiala xenobiotica in a non-Hodgkin lymphoma patient. Med Mycol. 2009 Feb; 47(1):95-9. Aoyama Y, Nomura M, Yamanaka S, Ogawa Y, Kitajima Y. PMID: 19107636.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    167. Generation of mouse induced pluripotent stem cells without viral vectors. Science. 2008 Nov 07; 322(5903):949-53. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. PMID: 18845712.
      View in: PubMed   Mentions: 647     Fields:    Translation:AnimalsCells
    168. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation. 2008 Jul 29; 118(5):498-506. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK. PMID: 18625891.
      View in: PubMed   Mentions: 162     Fields:    Translation:AnimalsCells
    169. Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci. 2008 Jun 27; 363(1500):2079-87. Yamanaka S. PMID: 18375377.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    170. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008 Aug 01; 321(5889):699-702. Aoi T, Yae K, Nakagawa M, Ichisaka T, Okita K, Takahashi K, Chiba T, Yamanaka S. PMID: 18276851.
      View in: PubMed   Mentions: 359     Fields:    Translation:AnimalsCells
    171. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008 Jan; 26(1):101-6. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. PMID: 18059259.
      View in: PubMed   Mentions: 889     Fields:    Translation:AnimalsCells
    172. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30; 131(5):861-72. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. PMID: 18035408.
      View in: PubMed   Mentions: 5825     Fields:    Translation:HumansAnimalsCells
    173. New advances in iPS cell research do not obviate the need for human embryonic stem cells. Cell Stem Cell. 2007 Oct 11; 1(4):367-8. Hyun I, Hochedlinger K, Jaenisch R, Yamanaka S. PMID: 18371375.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    174. Reprogramming somatic cells towards pluripotency by defined factors. Curr Opin Biotechnol. 2007 Oct; 18(5):467-73. Lewitzky M, Yamanaka S. PMID: 18024106.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansCells
    175. Drosophila NAT1, a homolog of the vertebrate translational regulator NAT1/DAP5/p97, is required for embryonic germband extension and metamorphosis. Dev Growth Differ. 2007 Sep; 49(7):623-34. Yoshikane N, Nakamura N, Ueda R, Ueno N, Yamanaka S, Nakamura M. PMID: 17716306.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    176. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007 Jun 07; 1(1):39-49. Yamanaka S. PMID: 18371333.
      View in: PubMed   Mentions: 243     Fields:    Translation:HumansAnimalsCells
    177. Generation of germline-competent induced pluripotent stem cells. Nature. 2007 Jul 19; 448(7151):313-7. Okita K, Ichisaka T, Yamanaka S. PMID: 17554338.
      View in: PubMed   Mentions: 1392     Fields:    Translation:AnimalsCells
    178. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc. 2007; 2(12):3081-9. Takahashi K, Okita K, Nakagawa M, Yamanaka S. PMID: 18079707.
      View in: PubMed   Mentions: 326     Fields:    Translation:AnimalsCells
    179. [Induction of pluripotent stem cells from mouse fibroblast cultures]. Tanpakushitsu Kakusan Koso. 2006 Dec; 51(15):2346-51. Yamanaka S, Takahashi K. PMID: 17154061.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    180. Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. Genes Cells. 2006 Oct; 11(10):1225-37. Nimura K, Ishida C, Koriyama H, Hata K, Yamanaka S, Li E, Ura K, Kaneda Y. PMID: 16999741.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    181. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006 Aug 25; 126(4):663-76. Takahashi K, Yamanaka S. PMID: 16904174.
      View in: PubMed   Mentions: 7207     Fields:    Translation:HumansAnimalsCells
    182. Esg1, expressed exclusively in preimplantation embryos, germline, and embryonic stem cells, is a putative RNA-binding protein with broad RNA targets. Dev Growth Differ. 2006 Aug; 48(6):381-90. Tanaka TS, Lopez de Silanes I, Sharova LV, Akutsu H, Yoshikawa T, Amano H, Yamanaka S, Gorospe M, Ko MS. PMID: 16872451.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    183. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev Biol. 2006 Jul 21; 6:34. Imamura M, Miura K, Iwabuchi K, Ichisaka T, Nakagawa M, Lee J, Kanatsu-Shinohara M, Shinohara T, Yamanaka S. PMID: 16859545.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    184. Identification and targeted disruption of the mouse gene encoding ESG1 (PH34/ECAT2/DPPA5). BMC Dev Biol. 2006 Feb 28; 6:11. Amano H, Itakura K, Maruyama M, Ichisaka T, Nakagawa M, Yamanaka S. PMID: 16504174.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    185. [Molecular mechanisms underlying pluripotency of embryonic stem cells]. Seikagaku. 2006 Jan; 78(1):27-33. Yamanaka S. PMID: 16491909.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    186. Identification of genes involved in tumor-like properties of embryonic stem cells. Methods Mol Biol. 2006; 329:449-58. Takahashi K, Ichisaka T, Yamanaka S. PMID: 16846009.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    187. Utilization of digital differential display to identify novel targets of Oct3/4. Methods Mol Biol. 2006; 329:223-31. Tokuzawa Y, Maruyama M, Yamanaka S. PMID: 16845994.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    188. Intracellular signaling pathways regulating pluripotency of embryonic stem cells. Curr Stem Cell Res Ther. 2006 Jan; 1(1):103-11. Okita K, Yamanaka S. PMID: 18220859.
      View in: PubMed   Mentions: 45     Fields:    Translation:AnimalsCells
    189. Differential membrane localization of ERas and Rheb, two Ras-related proteins involved in the phosphatidylinositol 3-kinase/mTOR pathway. J Biol Chem. 2005 Sep 23; 280(38):32768-74. Takahashi K, Nakagawa M, Young SG, Yamanaka S. PMID: 16046393.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    190. Complete and durable remission of refractory mantle cell lymphoma with repeated rituximab monotherapy. Int J Hematol. 2005 May; 81(4):319-22. Ishiyama K, Takami A, Okumura H, Ozaki J, Shimadoi S, Yamanaka S, Nakao S. PMID: 15914363.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. [Mechanism for maintaining pluripotency in embryonic stem cells and inner cell mass]. Tanpakushitsu Kakusan Koso. 2005 May; 50(6 Suppl):546-50. Nakagawa M, Yamanaka S. PMID: 15926478.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    192. Differential roles for Sox15 and Sox2 in transcriptional control in mouse embryonic stem cells. J Biol Chem. 2005 Jul 01; 280(26):24371-9. Maruyama M, Ichisaka T, Nakagawa M, Yamanaka S. PMID: 15863505.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCells
    193. Evolutionarily conserved non-AUG translation initiation in NAT1/p97/DAP5 (EIF4G2). Genomics. 2005 Mar; 85(3):360-71. Takahashi K, Maruyama M, Tokuzawa Y, Murakami M, Oda Y, Yoshikane N, Makabe KW, Ichisaka T, Yamanaka S. PMID: 15718103.
      View in: PubMed   Mentions: 20     Fields:    Translation:Cells
    194. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem. 2004 Oct 08; 279(41):43013-8. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. PMID: 15299027.
      View in: PubMed   Mentions: 68     Fields:    Translation:AnimalsCells
    195. Expression profiling with arrays of randomly disrupted genes in mouse embryonic stem cells leads to in vivo functional analysis. Proc Natl Acad Sci U S A. 2004 Mar 23; 101(12):4170-4. Matsuda E, Shigeoka T, Iida R, Yamanaka S, Kawaichi M, Ishida Y. PMID: 15010531.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    196. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 2003 May 30; 113(5):631-42. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. PMID: 12787504.
      View in: PubMed   Mentions: 918     Fields:    Translation:AnimalsCells
    197. Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature. 2003 May 29; 423(6939):541-5. Takahashi K, Mitsui K, Yamanaka S. PMID: 12774123.
      View in: PubMed   Mentions: 119     Fields:    Translation:AnimalsCells
    198. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol. 2003 Apr; 23(8):2699-708. Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, Yamanaka S. PMID: 12665572.
      View in: PubMed   Mentions: 78     Fields:    Translation:AnimalsCells
    199. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors. Arterioscler Thromb Vasc Biol. 1998 Jun; 18(6):1013-20. Qian X, Balestra ME, Yamanaka S, Borén J, Lee I, Innerarity TL. PMID: 9633945.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    200. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 1997 Feb 01; 11(3):321-33. Yamanaka S, Poksay KS, Arnold KS, Innerarity TL. PMID: 9030685.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    201. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem. 1996 May 10; 271(19):11506-10. Yamanaka S, Poksay KS, Driscoll DM, Innerarity TL. PMID: 8626710.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    202. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem. 1994 Aug 26; 269(34):21725-34. Yamanaka S, Poksay KS, Balestra ME, Zeng GQ, Innerarity TL. PMID: 8063816.
      View in: PubMed   Mentions: 24     Fields:    Translation:AnimalsCells
    Shinya's Networks
    Concepts (731)
    Derived automatically from this person's publications.
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _